Amgen names senior VP, global regulatory affairs
This article was originally published in Scrip
Executive Summary
Amgen has named Dr Steven K Galson senior vice-president, global regulatory affairs and safety – effective 19 May 2014. Dr Galson joined the Thousand Oaks, California-based company in October 2010 as vice-president of global regulatory affairs. Prior to joining Amgen he was senior vice-president for civilian health operations and chief health scientist at Science Applications International Corporation.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.